BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 2999173)

  • 1. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new serum-based assay for fat cell-binding immunoglobulins: application to the detection of the thyrotropin receptor antibodies of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):10-5. PubMed ID: 2999174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization, partial purification, and characterization of thyrotropin receptors in solubilized guinea pig fat cell membranes.
    Iida Y; Amir SM; Ingbar SH
    Endocrinology; 1987 Nov; 121(5):1627-36. PubMed ID: 3665836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
    Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
    Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases.
    Tao TW; Kriss JP
    J Clin Endocrinol Metab; 1982 Nov; 55(5):935-40. PubMed ID: 6126489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes.
    Kishihara M; Nakao Y; Baba Y; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1979 Nov; 49(5):706-11. PubMed ID: 226558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
    Loeffler M; Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves' disease.
    Macchia E; Fenzi GF; Monzani F; Bartalena L; Lippi F; Aloisio V; Cupini C; Baschieri L; Pinchera A
    J Endocrinol Invest; 1983 Oct; 6(5):375-8. PubMed ID: 6141201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.
    Baker JR; Lukes YG; Burman KD
    J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
    Abe Y
    Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of 125I-labeled receptor-purified Graves' immunoglobulins: properties of their binding to human thyroid membranes.
    Endo K; Borges M; Amir S; Ingbar SH
    J Clin Endocrinol Metab; 1982 Sep; 55(3):566-76. PubMed ID: 6284786
    [No Abstract]   [Full Text] [Related]  

  • 17. Antithyrotropin antibodies in the sera of Graves' disease patients.
    Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD
    J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y; Hamazu M; Kajita Y; Nagata A
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotrophin-binding-inhibition assay: comparison of crude and purified membrane preparations.
    Garcia AA; Hunter AN; Wilkins JA; von Westarp C
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):199-204. PubMed ID: 6291296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte-TSH-receptor-related antibodies in Graves' disease detected by immunoprecipitation.
    Konishi J; Iida Y; Kasagi K; Ikekubo K; Kuma K; Torizuka K
    Endocrinol Jpn; 1982 Apr; 29(2):219-26. PubMed ID: 6127208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.